Wells Fargo & Company Gbs Inc. Transaction History

Wells Fargo & Company

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$0.0 - $0.47 $0 - $0	2 Added 2.2%	93 $0
Q3 2022 Nov 14, 2022	BUY	$0.39 - $0.79 $5 - $11	14 Added 18.18%	91 $0
Q2 2022 Aug 12, 2022	BUY	$0.56 - $1.31 $3 - $7	6 Added 8.45%	77 $0
Q1 2022 May 16, 2022	BUY	$0.43 - $1.7 $0 - $1	1 Added 1.43%	71 $0
Q4 2021 Feb 14, 2022	BUY	$1.26 - $2.45 $15 - $29	12 Added 20.69%	70 $0
Q3 2021 Nov 15, 2021	BUY	$2.26 - $4.29 $108 - $205	48 Added 480.0%	58 $0
Q2 2021 Aug 16, 2021	BUY	$2.65 - $5.72 $2 - $5	1 Added 11.11%	10 $0
Q1 2021 May 13, 2021	BUY	$5.21 - $8.25 $46 - $74	9 New	9 $0

Ticker GBS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,889,900
Description
GBS Inc. operates as a biosensor diagnostic technology company. It offers Saliva Glucose Biosensor that uses saliva to measure glucose non-invasively. The company also focuses on developing COV2 test, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, t...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.